Who needs to know?
Primary Care, Diabetes and Cardiology Specialist Teams
What have we found?
Our findings suggests that, in people with Type 2 diabetes, concurrent treatment with metformin attenuates the observed higher cardiovascular and mortality risk in ex- and current smokers.
In addition to smoking cessation support, treatment with metformin, particularly in ex- and current smokers, should be encouraged.